Skip to content

Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device

Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device in People With Chronic Headaches

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06996600
Enrollment
29
Registered
2025-05-30
Start date
2025-05-02
Completion date
2025-12-31
Last updated
2025-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus

Brief summary

This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during headache and non-headache periods.

Interventions

Wireless wearable thermal anisotropy measurement device designed for use at home

Sponsors

Rhaeos, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Existing ventriculoperitoneal CSF shunt 2. Subject experiencing ongoing headaches including at least 15 headache days per month for the past 3 months 3. Region of intact skin overlying an unambiguously identifiable palpable chronically indwelling ventricular shunt which crosses the clavicle and is appropriate in size for application of the study device 4. Available for remote and in-person follow-up during the 30-day measurement period 5. Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes) 6. Subject or caregiver is able to clearly communicate and document information and shunt symptoms in English 7. Subject is at least 6 years old but not more than 80 years old

Exclusion criteria

1. Presence of more than one distal shunt catheter in the study device measurement region 2. Shunt is not palpable due to depth or depth of shunt where the device will be placed is greater than 4 mm per ultrasound evaluation 3. Presence of an interfering open wound or edema in the study device measurement region 4. Subject-reported history of serious adverse skin reactions to silicone-based adhesives 5. Investigator judges that the subject is likely to be lost to follow-up due to unavailability or clinical outcome being unobtainable 6. Investigator judges that the subject is unlikely to successfully take reliable measurements at home 7. Investigator judges that the subject/subject's caretaker would not be able to successfully place the device without assistance 8. Use of the study device would interfere with standard patient care, or emergency surgery that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject 9. Prior enrollment in this study 10. Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study

Design outcomes

Primary

MeasureTime frameDescription
Correlation Between Study Device Flow Measurement and Subject-reported Headaches30 daysExploratory analysis to determine the relationship between headaches (subject-reported headache and non-headache periods) and measured flow. Data will be analyzed using the Point-Biserial Correlation Coefficient between headaches periods (headache and non-headache periods) and thermal flow score (flow score derived from algorithm analysis of raw thermal data)

Countries

United States

Contacts

Primary ContactAnna Somera
clinical@rhaeos.com855-814-3569

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026